18 Apr 2019

MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

This alert highlights two reports of fatal adverse reactions to yellow fever vaccine and the importance of a detailed risk assessment before vaccination MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

The Medicines and Healthcare products Regulatory Agency (MHRA) has published an alert following two fatal adverse reactions to yellow fever vaccine. This publication reinforces the importance of a detailed individual risk assessment before administering yellow fever vaccine especially for those who may be immunocompromised or aged 60 years and older. 

NaTHNaC have been working closely with the MHRA following these two reports of fatal adverse reactions. Measures to minimise risks are being reviewed by an Expert Working Group convened by the Commission on Human Medicines and any updates will be highlighted in due course.

Resources

Heatwave reminder for mainland Europe

Hot weather advice for travellers to mainland European countries Read more

Access to medications abroad during the coronavirus (COVID-19) pandemic

Advice for travellers who cannot immediately return to the UK Read more

Coronavirus (COVID-19) pandemic: advice for those returning from abroad

Avoiding infection during your journey home and preventive measures to take on your return Read more

COVID-19 (coronavirus): advice for Humanitarian Aid workers

Advice for UK humanitarian aid workers deployed overseas during COVID-19 pandemic Read more

Coronavirus (COVID-19) pandemic: global situation update

An update of global situation highlighting areas of concern Read more
Back to Top

VIEW FULL INDEX